Loading
Envoy Medical, Inc. Stock: price and insider trades · United States
US·Mcap US$54.1M
No insider purchase over the last 90 days. The latest was filed 17 Feb 2026.
Envoy Medical, Inc.: what insiders have been doing
Envoy Medical, Inc. is a listed company. Filings by its managers are published through SEC (Form 4). Over the twelve months to 18 October 2026, 8 filings were filed, from 6 insiders.
Not one open-market sale was filed. On the buying side, 6 insiders reported 6 purchases totalling €6.9M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The buyers include 3 senior executives, 1 finance chief and 1 chief executive. One trade stands out by size: a purchase of €6.3M from Taylor Glen A, disclosed on 17 February 2026.
Within a 30-day window, 6 purchases overlapped with buying by a second insider. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The last purchase on record was published on 17 February 2026, which is 243 days ago. The median gap between a trade and its publication by SEC (Form 4) is 5 days. US insiders must file a Form 4 within two business days of a trade.
With 8 filings in twelve months, the company is quieter than the median of 19 filings across the 5,808 companies we follow on the same exchange. Since 2023, the database holds 14 purchases and no sales by insiders of the company.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
27
Thresholds
n/a
Buy Volume
€7M
14 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleCharles Brynelsen4 buys
Mona Chetan Patel4 buys
Brent T. Lucas1 buy
Glen A. Taylor1 buy
Robert Potashnick1 buy
Susan Kantor1 buy
Since the insiders bought
- -2.2%Entry US$0.76 · Close at T+90 US$0.74
- -2.2%Entry US$0.76 · Close at T+90 US$0.74
- -2.2%Entry US$0.76 · Close at T+90 US$0.74
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.70
Analyst consensus
2 analysts1.00/5
US$2.00Target US$2.00(+185%)US$2.00
Income statement
RevenueUS$241k
Gross profit-US$633k-263% margin
EBITDA-US$21.9M-9072% margin
Net income-US$28.7M-11892.9% margin
Valuation
PER (forward)-3.2x
P/Book14.6x
Beta1.90
Balance sheet & cash
Market capUS$54.1M
Total debtUS$919k
Free Cash Flow-US$18.4M
Debt / Equity22%
Profitability & ownership
ROA-86.5%
% insiders40.2%
% institutions23.3%
Last declaration on 4 June 2026
Declarations27 total
32,856 shares@ US$0.5990.031% mcap25.1% of flowClass A Common StockSEC:0000914190-26-000095:0
18,750,000 shares@ US$0.40100.0% of flowClass A Common StockSEC:0001104659-26-016182:0
Canonical exit: 13 May 2026 (T+90)
312,500 shares@ US$0.4081.3% of flowClass A Common StockSEC:0000914190-26-000028:0
Canonical exit: 13 May 2026 (T+90)
212,500 shares@ US$0.40100.0% of flowClass A Common StockSEC:0000914190-26-000027:0
Canonical exit: 13 May 2026 (T+90)
96,150 shares@ US$0.40100.0% of flowClass A Common StockSEC:0000914190-26-000026:0
Canonical exit: 13 May 2026 (T+90)
1,000,000 shares@ US$0.4082.2% of flowClass A Common StockSEC:0000914190-26-000025:0
Canonical exit: 13 May 2026 (T+90)
62,500 shares@ US$0.4031.2% of flowClass A Common StockSEC:0000914190-26-000024:0
Canonical exit: 13 May 2026 (T+90)
18,105 shares@ US$0.71316.5% of flowClass A Common StockSEC:0000914190-25-000054:0
2,500 shares@ US$1.472.5% of flowClass A Common StockSEC:0001062993-25-011661:0
Canonical exit: 9 Sept 2025 (T+90)
10,000 shares@ US$1.469.8% of flowClass A Common StockSEC:0001062993-25-011320:0
Canonical exit: 4 Sept 2025 (T+90)
5,165 shares@ US$1.9414.0% of flowClass A Common StockSEC:0001062993-25-011296:0
2,000 shares@ US$1.68340.7% of flowClass A Common StockSEC:0001062993-25-010396:0
Canonical exit: 20 Aug 2025 (T+90)
13,000 shares@ US$1.64334.6% of flowClass A Common StockSEC:0001062993-25-010396:1
Canonical exit: 21 Aug 2025 (T+90)
35,000 shares@ US$1.647812.4% of flowClass A Common StockSEC:0001062993-25-010396:2
Canonical exit: 25 Aug 2025 (T+90)
1,028,986 shares0Class A Common Stock, par value $0.0001 per shareSEC:0001140361-24-050420:0
34,705 shares0Class A Common StockSEC:0001140361-24-050422:0
2,500 shares@ US$2.27954.1% of flowClass A Common StockSEC:0001062993-24-019574:0
Canonical exit: 18 Feb 2025 (T+90)
1,000,000 shares0Class A Common Stock, par value $0.0001 per shareSEC:0001062993-24-019529:0
18,182 shares0Class A Common StockSEC:0001062993-24-019530:0
1,000 shares@ US$3.202.2% of flowClass A Common StockSEC:0001062993-24-016486:0
Canonical exit: 8 Dec 2024 (T+90)
74,784 shares0Class A Common StockSEC:0001062993-24-013065:0
10,000 shares@ US$0.9813.3% of flowClass A Common StockSEC:0001062993-23-021438:0
Canonical exit: 19 Feb 2024 (T+90)
25,000 sharesClass A Common Stock, par value $0.0001 per shareSEC:0001062993-23-018935:0
2,490,000 sharesClass A Common Stock, par value $0.0001 per shareSEC:0001062993-23-018937:0
25,000 shares0Class A Common Stock, par value $0.0001 per shareSEC:0001062993-23-018936:0
25 of 27 declarations
About Envoy Medical, Inc.
Envoy Medical, Inc. is a company focused on developing innovative medical solutions. It is listed on the XNAS market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
